IRIS  Catalogo Istituzionale della Ricerca dell'Università degli Studi del Molise

PERROTTA, Fabio Massimo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.007
EU - Europa 1.951
AF - Africa 274
AS - Asia 246
SA - Sud America 18
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 8
Totale 4.515
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.000
IE - Irlanda 769
CI - Costa d'Avorio 270
IT - Italia 204
AT - Austria 192
FI - Finlandia 173
UA - Ucraina 160
DE - Germania 132
CN - Cina 121
FR - Francia 84
SE - Svezia 79
SG - Singapore 71
GB - Regno Unito 54
PL - Polonia 52
IN - India 23
RU - Federazione Russa 16
BE - Belgio 15
AU - Australia 11
BR - Brasile 10
EU - Europa 8
NL - Olanda 7
CA - Canada 6
IR - Iran 6
TR - Turchia 5
CH - Svizzera 4
CL - Cile 4
CO - Colombia 4
TH - Thailandia 3
CZ - Repubblica Ceca 2
EG - Egitto 2
ES - Italia 2
IL - Israele 2
JP - Giappone 2
KR - Corea 2
BD - Bangladesh 1
DK - Danimarca 1
GR - Grecia 1
HK - Hong Kong 1
ID - Indonesia 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
MA - Marocco 1
MK - Macedonia 1
MX - Messico 1
MY - Malesia 1
NO - Norvegia 1
PH - Filippine 1
RO - Romania 1
RS - Serbia 1
SA - Arabia Saudita 1
SC - Seychelles 1
TW - Taiwan 1
VN - Vietnam 1
Totale 4.515
Salva come PNG Salva come JPEG
Città #
Dublin 769
Chandler 439
Jacksonville 377
Abidjan 270
Vienna 191
Helsinki 149
Ann Arbor 117
Wilmington 106
San Mateo 78
Princeton 61
Houston 52
Rome 52
Warsaw 52
Woodbridge 50
Singapore 46
Boardman 43
Dearborn 42
New York 31
Beijing 28
Ashburn 26
Molise 20
Redwood City 20
Los Angeles 17
Brussels 15
Jinan 14
Mountain View 11
Milan 10
Nanjing 9
Manchester 8
Borås 7
Esslingen am Neckar 7
Leawood 7
Rochester 7
Shenyang 7
Ardabil 6
Augusta 6
Haikou 6
Ningbo 6
Rockville 6
Changsha 5
Chennai 5
Falls Church 5
Seattle 5
Zhengzhou 5
Falkenstein 4
Fleet 4
Frankfurt am Main 4
Guangzhou 4
Hefei 4
London 4
Paola 4
Taiyuan 4
Tianjin 4
Ariccia 3
Bangkok 3
Chicago 3
Ilmenau 3
Lappeenranta 3
Monmouth Junction 3
Norwalk 3
Shanghai 3
Simi Valley 3
Taizhou 3
Toronto 3
Auburn Hills 2
Avignon 2
Bari 2
Bologna 2
Cagliari 2
Campi Bisenzio 2
Cernusco sul Naviglio 2
Chiaravalle Centrale 2
Eden Prairie 2
Fairfield 2
Florence 2
Forlì 2
Impruneta 2
Jaipur 2
Johns Island 2
João Pessoa 2
Kunming 2
Lanzhou 2
Letchworth Garden City 2
Naples 2
Novokuznetsk 2
Olomouc 2
Padova 2
Pune 2
Quzhou 2
Rende 2
Rocca d'Evandro 2
San Bernardino 2
San Francisco 2
Sant'Antimo 2
Sarzana 2
Sheffield 2
Stockport 2
São Paulo 2
Tokyo 2
Turin 2
Totale 3.334
Salva come PNG Salva come JPEG
Nome #
Spondiloartriti assiali: dalla patogenesi della neoformazione ossea alla valutazione di possibili biomarcatori di attività di malattia e remissione clinica 229
An ultrasonographic study of enthesis in early psoriatic arthritis patients naive to traditional and biologic DMARDs treatment 120
Analysis of potential determinants for a treat-to-target strategy in psoriatic arthritis patients from a real-world setting 103
Validity, responsiveness and feasibility of an Italian version of the Canadian Occupational Performance Measure for patients with ankylosing spondylitis 95
Remission in ankylosing spondylitis treated with anti-TNF-α drugs: a national multicentre study. 93
Assessment of response to treatment, remission, and minimal disease activity in axial psoriatic arthritis treated with tumor necrosis factor inhibitors 91
Incidence of rheumatoid arthritis, psoriatic arthritis and polymyalgia rheumatica in an inland area of central Italy: results of the CAMPO-RHE study 91
Sustained Very Low Disease Activity and Remission in Psoriatic Arthritis Patients 89
Beyond TNF Inhibitors: New Pathways and Emerging Treatments for Psoriatic Arthritis 83
Elderly psoriatic arthritis patients on TNF-α blockers: results of an Italian multicenter study on minimal disease activity and drug discontinuation rate 83
Residual disease activity in rheumatoid arthritis patients treated with subcutaneous biologic drugs that achieved remission or low disease activity: a longitudinal observational study 83
Chronic periaortitis with retroperitoneal fibrosis successfully treated with first line tocilizumab monotherapy: a case report 83
Assessment of semaphorin 3A and its role in bone remodelling in a group of ankylosing spondylitis patients 82
Unmet Needs in Axial Spondyloarthritis 82
Comparison of composite indices tailored for psoriatic arthritis treated with csDMARD and bDMARD: A cross-sectional analysis of a longitudinal cohort 81
Secukinumab for ankylosing spondylitis and psoriatic arthritis 80
Defining low disease activity states in psoriatic arthritis using novel composite disease instruments 78
Assessment of subclinical atherosclerosis in ankylosing spondylitis: Correlations with disease activity indices 78
Mesenchimal stem cells: A possible role in the pathogenesis and treatment of spondyloarthritis 77
Validation of the Italian version of proposed GRAPPA flare questionnaire for patients with psoriatic arthritis 76
From clinical remission to residual disease activity in spondyloarthritis and its potential treatment implications 76
The role of IL-17 in the treatment of psoriatic arthritis 75
An Assessment of Hand Erosive Osteoarthritis: Correlation of Radiographic Severity with Clinical, Functional and Laboratory Findings 75
Predictors of loss of remission and disease flares in patients with axial spondyloarthritis receiving antitumor necrosis factor treatment: A retrospective study 74
Minimal Disease Activity and Remission in Psoriatic Arthritis Patients Treated with Anti-TNF-α Drugs 73
An overview of low disease activity and remission in psoriatic arthritis. 72
Remission in nonradiographic axial spondyloarthritis treated with anti-tumor necrosis factor-α drugs: an Italian multicenter study. 71
Beyond the joint: Subclinical atherosclerosis in rheumatoid arthritis 69
Predictive factors for partial remission according to the Ankylosing Spondylitis Assessment Study working group in patients with ankylosing spondylitis treated with anti-TNFα drugs 69
Subcutaneous anti-TNF alfa induced sustained minimal disease activity and remission in psoriatic arthritis patients: a retrospective study 69
Multimorbidity and comorbidity in psoriatic arthritis–a perspective 66
Patient's global assessment as an outcome measure for psoriatic arthritis in clinical practice: A surrogate for measuring low disease activity? 66
Rapid effectiveness of certolizumab pegol in non-radiographic axial spondyloarthritis. 65
The sex influence on response to tumor necrosis factor-α inhibitors and remission in axial spondyloarthritis 63
Role of comorbidities in spondyloarthritis including psoriatic arthritis 63
Psoriatic arthritis: is it time to treat-to-target or target to treat? 62
Assessment of bone morphogenic protein 2 and interleukine-17A in patients with axial spondyloarthritis and their potential role in the new bone formation: a cross-sectional study 61
New approved drugs for psoriatic arthritis. 61
Assessment of the Patient Acceptable Symptom State (PASS) in psoriatic arthritis: Association with disease activity and quality of life indices 61
Effectiveness of adalimumab for the treatment of psoriatic arthritis: An Italian real-life retrospective study 57
Cardiovascular Risk Prediction in Ankylosing Spondylitis: From Traditional Scores to Machine Learning Assessment 56
Serum Sclerostin as a Possible Biomarker in Ankylosing Spondylitis: A Case-Control Study 53
Psoriatic arthritis, psoriatic disease, or psoriatic syndrome? 53
Impact of Comorbidities on Disease Activity, Patient Global Assessment, and Function in Psoriatic Arthritis: A Cross-Sectional Study 53
Case report of polymyalgia rheumatica in a male patient with three different neoplasms treated with pembrolizumab 52
Impact of physical activity on disability risk in elderly patients hospitalized for mild acute diverticulitis and diverticular bleeding undergone conservative management 52
To move or not to move: The paradoxical effect of physical exercise in axial spondyloarthritis 52
Clinical and ultrasonography assessment of peripheral enthesitis in ankylosing spondylitis 50
Occult axial involvement in patients with psoriatic arthritis mutilans: a case report 50
Assessment of widespread and extra-articular pain in psoriatic arthritis: a case-control study 49
Improvement of Function and Its Determinants in a Group of Axial Spondyloarthritis Patients Treated with TNF Inhibitors: A Real-Life Study 49
Ultrasonographic and Clinical Assessment of Peripheral Enthesitis in Patients with Psoriatic Arthritis, Psoriasis, and Fibromyalgia Syndrome: The ULISSE Study 48
Dr. Lubrano, et al reply 48
New Insights in Physical Therapy and Rehabilitation in Axial Spondyloarthritis: A Review 44
TNF-alpha inhibitors for the six treatment targets of psoriatic arthritis 44
Residual disease activity and associated factors in Psoriatic Arthritis 43
Power Doppler ultrasonographic evaluation of enthesitis in psoriatic arthritis. A multi-center study 42
Clinical and imaging assessment of peripheral enthesitis in Ankylosing Spondylitis 41
Remission, low disease activity and improvement of pain and function in psoriatic arthritis patients treated with IL-12/23 and IL-17 inhibitors. A multicenter prospective study 36
Rheumatology Care in the Face of COVID-19 36
SARS-CoV-2 IgM False-Positivity in a Psoriatic Arthritis Patient Seropositive for Rheumatoid Factor and ACPA: An Interference of Immune Response? 29
MRI Assessment of Extra-axial Findings at Pelvic Sites in a Group of Axial-SpA Patients 29
Clinical Characteristics of Potential "Difficult-to-treat" Patients with Psoriatic Arthritis: A Retrospective Analysis of a Longitudinal Cohort 27
Dactylitis and Early Onset Psoriasis in Psoriatic Arthritis: Are they Markers of Disease Severity? A Clinical Study 26
Psoriatic Arthritis in Males and Females: Differences and Similarities 25
The "Climb" Towards Minimal Disease Activity in Psoriatic Arthritis 24
The Conundrum of Psoriatic Arthritis: a Pathogenetic and Clinical Pattern at the Midpoint of Autoinflammation and Autoimmunity 24
Therapeutic Targets for Ankylosing Spondylitis - Recent Insights and Future Prospects 22
New Insights in Physical Therapy and Rehabilitation in Psoriatic Arthritis: A Review 22
Constrictive Pericarditis With Massive Calcification in Systemic Sclerosis Treated With Pericardiectomy: A Case Report 22
Sequencing of Biologic and Target Synthetic Disease-Modifying Anti-Rheumatic Drugs in Psoriatic Arthritis: Are we Ready to Redefine the Treatment Strategy? A Perspective 21
Inflammatory bowel disease manifestations in spondyloarthritis: considerations for the clinician 19
Cardiovascular comorbidities in psoriatic arthritis: epidemiology and risk factors in two different European populations 18
Livelli aumentati di IL19 nel liquido sinoviale di pazienti con artrite psoriasica 17
Valutazione ecografica del tendine di Achille e dell'entesi rotulea nei giocatori di calcio e basket: potrebbe essere utile per prevedere lo sviluppo di lesioni muscolari e tendinee? 16
Valutazione dei fattori predittivi per il raggiungimento della remissione parziale (RP) secondo i criteri ASAS nei pazienti con Spondilite Anchilosante (SA) trattati con farmaci antagonisti del TNF 16
Use of Ultrasonography to Discriminate Psoriatic Arthritis from Fibromyalgia: A Post-Hoc Analysis of the ULISSE Study 15
Ultrasonographic Evaluation of Entheseal Fibrocartilage in Patients with Psoriatic Arthritis, Athletes and Healthy Controls: A Comparison Study 15
Extra-Articular Manifestations and Comorbidities in Psoriatic Disease: A Journey Into the Immunologic Crosstalk 15
Patient reported outcomes in early vs late diagnosis of psoriatic arthritis|Resultados informados por los pacientes en el diagnóstico precoz respecto a los pacientes con diagnóstico tardío en la artritis psoriásica 12
VALUTAZIONE DELLA REMISSIONE CLINICA SECONDO I CRITERI ASAS NEI PAZIENTI CON SPONDILOARTRITE ASSIALE TRATTATI CON FARMACI BIOLOGICI ANTAGONISTI DEL TNF ALPHA: STUDIO RETROSPETTIVO MULTICENTRICO 11
Elevated levels of IL-19 in the joints of patients with psoriatic arthritis 11
Triple jump for the optimal management of psoriatic arthritis: Diet, sleep and exercise - A review 9
Clinical Characteristics of "Severe" Peripheral Psoriatic Arthritis: A Retrospective Analysis of a Longitudinal Cohort 7
Assessment of Patient-Physician Interactions in Psoriatic Arthritis: National Results of the ASSIST Study 6
Sex-related differences in psoriatic arthritis 5
Sensitivity and Specificity of Composite Indices of Remission in Male and Female Patients With Psoriatic Arthritis: A Multicenter Cross-Sectional Study of Longitudinal Cohorts 5
Difficult to Treat and Refractory to Treatment in Psoriatic Arthritis 5
The assessment of the drug retention rate of secukinumab in patients with psoriatic arthritis in a real-life multicentre cohort 5
Identification of the Minimal Disease Activity Domains Achieved Based on Different Treatments in Psoriatic Arthritis 4
Two sides of management recommendations for psoriatic arthritis 3
Psoriatic Arthritis Acceptable Symptoms State: Does Sex Make a Difference? 1
Male Fertility in Spondyloarthritis: from Clinical Issues to Cytokines Milieu. A Narrative Review 1
Difficult-to-treat concept in Psoriatic Arthritis: analysis of two potential definitions in a large group of patients. A cross-sectional study 1
Totale 4.664
Salva come PNG Salva come JPEG
Categoria #
all - tutte 23.327
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.327
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020526 18 12 54 41 50 25 116 34 64 44 12 56
2020/2021582 20 57 4 83 103 28 76 12 76 15 99 9
2021/2022359 15 76 16 17 17 7 10 38 49 71 14 29
2022/20231.805 218 74 34 151 68 126 15 86 895 67 39 32
2023/2024473 132 68 34 19 23 51 2 33 17 23 19 52
2024/2025315 315 0 0 0 0 0 0 0 0 0 0 0
Totale 4.664